Oncolym: Began a Phase III trial in about 100 patients who haven't responded to standard treatment. The company, a business unit created by the Green Cross Corp

Alpha Therapeutic Corp., New York Product: Oncolym, 131-Iodine linked to Lym-1 antibody Indication: Refractory non-Hodg-kin's lymphoma Status: Began a Phase III trial in about 100 patients who haven'...